top of page
IV process.png

NOVEL ANTICOAGULANTS & ANTIDOTES

TRADITIONAL ANTICOAGULANTS & THEIR PROBLEMS

The blood coagulation cascade must be regulated in large numbers of health care situations, including during surgery, dialysis treatments, and in thrombotic diseases that can lead to deep clots, stroke, and death. Conventional intravenous anticoagulant drugs such as heparin are associated with serious side-effects and suffer from unpredictable dose response, and their biological activities are difficult to reverse (antidotes are unavailable, non-specific, have harmful side-effects, or are very expensive)

VOICE OF PHYSICIANS, PRACTITIONERS & SURGEONS

"We need something better than heparin."

OUR TECHNOLOGY

Using a new molecular engineering strategy, we have designed, created, and tested a family of functional RNA origami anticoagulants and a specific reversal agent to address the critical problems of traditional anticoagulants for better human health.

Specific – Our molecule specifically binds to targeted protein, offering precise control action and reduction of complications

Fast “On-Off” Action – With fast, safe and specific antidote, we are able to control “on-off” action of drug as we needed

Long-Circulation – Therapeutic agents with optimal size provide long-circulation times in body, offering benefits in long, complicated surgical procedures.

Heparin-Sensitive Patients – Our drugs would fill a void in health care for heparin-resistant and heparin-sensitive patients, and eradication of who are at risk for heparin-induced thrombocytopenia.

Products for Kidney Failure Patients – We rationally designed the optimal drug’s size to avoid renal filtration.

unsplash-8o_LkMpo8ug_edited_edited.jpg
contact us.png

HELP US TO
REALIZE THE IDEAL ANTICOAGULANT

To achieve the ideal anticoagulant, we need your valuable input.

 

With your feedback, we will design and engineer biomolecules for safe and effective anticoagulation for human health in general and your loved ones in particular.

bottom of page